article thumbnail

Medicare Unveils First 10 Negotiated Drug Prices

Med Page Today

(MedPage Today) -- Sitagliptin (Januvia) saw the greatest drop in price among the list of 10 drugs whose new prices were announced Thursday under Medicare's drug price negotiation program. The price negotiation program was passed in 2022 as part.

Medicare 142
article thumbnail

One Way to Spot Early Cognitive Decline? Medicare Wellness Visits

Med Page Today

(MedPage Today) -- A Medicare annual wellness visit (AWV) was associated with greater recognition of mild cognitive impairment in older adults, a population-based cohort study in Texas showed. Compared with those who didn't have an annual visit.

Medicare 116
article thumbnail

The heart of the question: Who can get Medicare-covered weight loss medicine?

Science Daily - Heart Disease

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans apply.

Medicare 117
article thumbnail

Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients

Med Page Today

(MedPage Today) -- Medicare will cover the weight-loss drug semaglutide (Wegovy) under its Part D drug program for patients with overweight or obesity who have preexisting heart disease and need the drug to prevent heart attacks or strokes, the.

Medicare 132
article thumbnail

CMS Releases 2025 Medicare Physician Fee Schedule and Hospital OPPS Final Rules

American College of Cardiology

The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule and the 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgery Center (ASC) final rule on Nov.

CMS 60
article thumbnail

Medicare Drug Cuts Target CVD Meds, Drive Debates

CardiacWire

The White House finally unveiled its negotiated Medicare drug prices , bringing 38%-76% reductions to the first 10 drugs, while drawing mixed industry reactions. Medicare drug price negotiations are one of the highlighted results of 2022’s Inflation Reduction Act, allowing CMS to negotiate drug prices for the very first time.

article thumbnail

AMA Releases Statement Urging Congress to Address Medicare Reform During Lame Duck

DAIC

15, 2024 — The American Medical Association recently released a statement urging Congress to address Medicare reform during the lame duck session later this year. The House position is clear now that 233 members of the House – a solid, bipartisan majority – are urging the Speaker to tackle Medicare reform during the lame duck.